Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016, Article ID 3830424, 9 pages
http://dx.doi.org/10.1155/2016/3830424
Research Article

Miglustat Reverts the Impairment of Synaptic Plasticity in a Mouse Model of NPC Disease

1Department of Medical System, University of Rome Tor Vergata, 00133 Rome, Italy
2Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, 00161 Rome, Italy
3IRCCS San Raffaele Pisana, 00163 Rome, Italy
4Department of Biology, University of Rome Tor Vergata, 00133 Rome, Italy
5National Centre for Rare Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy

Received 24 July 2015; Revised 15 October 2015; Accepted 1 November 2015

Academic Editor: Lucas Pozzo-Miller

Copyright © 2016 G. D’Arcangelo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Vanier, “Niemann-Pick disease type C,” Orphanet Journal of Rare Diseases, vol. 5, article 16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. T. Vanier, “Complex lipid trafficking in Niemann-Pick disease type C,” Journal of Inherited Metabolic Disease, vol. 38, no. 1, pp. 187–199, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Strupp, O. Kremmyda, C. Adamczyk et al., “Central ocular motor disorders, including gaze palsy and nystagmus,” Journal of Neurology, vol. 261, no. 2, pp. 542–558, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. E. Shapiro, G. M. Pastores, J. Gianutsos, C. Luzy, and E. H. Kolodny, “Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment,” Genetics in Medicine, vol. 11, no. 6, pp. 425–433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Wraith, D. Vecchio, E. Jacklin et al., “Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial,” Molecular Genetics and Metabolism, vol. 99, no. 4, pp. 351–357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Benito, J. M. García Fernández, and C. O. Mellet, “Pharmacological chaperone therapy for Gaucher disease: a patent review,” Expert Opinion on Therapeutic Patents, vol. 21, no. 6, pp. 885–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Lyseng-Williamson, “Miglustat: a review of its use in Niemann-Pick disease Type C,” Drugs, vol. 74, no. 1, pp. 61–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Zervas, K. L. Somers, M. A. Thrall, and S. U. Walkley, “Critical role for glycosphingolipids in Niemann-Pick disease type C,” Current Biology, vol. 11, no. 16, pp. 1283–1287, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Becher, J. H. White, and R. A. Jeffrey McIlhinney, “The γ-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum,” Journal of Neurochemistry, vol. 79, no. 4, pp. 787–795, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Brachet, S. Norwood, J. F. Brouwers et al., “LTP-triggered cholesterol redistribution activates Cdc42 and drives AMPA receptor synaptic delivery,” The Journal of Cell Biology, vol. 208, no. 6, pp. 791–806, 2015. View at Publisher · View at Google Scholar
  11. C. Frank, S. Rufini, V. Tancredi, R. Forcina, D. Grossi, and G. D'Arcangelo, “Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus,” Experimental Neurology, vol. 212, no. 2, pp. 407–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. K. Loftus, J. A. Morris, E. D. Carstea et al., “Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene,” Science, vol. 277, no. 5323, pp. 232–235, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. A. De Simoni and L. M. Yu, “Preparation of organotypic hippocampal slice cultures: interface method,” Nature Protocols, vol. 1, no. 3, pp. 1439–1445, 2006. View at Publisher · View at Google Scholar
  14. M. Racaniello, A. Cardinale, C. Mollinari et al., “Phosphorylation changes of CaMKII, ERK1/2, PKB/Akt kinases and CREB activation during early long-term potentiation at Schaffer collateral-CA1 mouse hippocampal synapses,” Neurochemical Research, vol. 35, no. 2, pp. 239–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. G. D'Arcangelo, D. Grossi, G. De Chiara et al., “Glutamatergic neurotransmission in a mouse model of Niemann-Pick Type C disease,” Brain Research, vol. 1396, pp. 11–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Lynch, “Long-term potentiation and memory,” Physiological Reviews, vol. 84, no. 1, pp. 87–136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Schmitt, E. S. Guire, T. Saneyoshi, and T. R. Soderling, “Calmodulin-dependent kinase kinase/calmodulin kinase I activity gates extracellular-regulated kinase-dependent long-term potentiation,” The Journal of Neuroscience, vol. 25, no. 5, pp. 1281–1290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Y. Zhou, S. Y. Xu, Y. G. Yan, H. M. Yu, S. C. Ling, and J. H. Luo, “Decreased phurinergic inibition of synaptic activity in a mouse model of Niemann-Pick disease type C,” Hippocampus, vol. 21, no. 2, pp. 212–219, 2011. View at Publisher · View at Google Scholar
  19. T. V. P. Bliss and G. L. Collingridge, “A synaptic model of memory: long-term potentiation in the hippocampus,” Nature, vol. 361, no. 6407, pp. 31–39, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Malenka, “Synaptic plasticity and AMPA receptor trafficking,” Annals of the New York Academy of Sciences, vol. 1003, pp. 1–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Linetti, A. Fratangeli, E. Taverna et al., “Cholesterol reduction impairs exocytosis of synaptic vesicles,” Journal of Cell Science, vol. 123, no. 4, pp. 595–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Sebastião, M. Colino-Oliveira, N. Assaife-Lopes, R. B. Dias, and J. A. Ribeiro, “Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases,” Neuropharmacology, vol. 64, pp. 97–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Frank, A. M. Giammarioli, R. Pepponi, C. Fiorentini, and S. Rufini, “Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture,” FEBS Letters, vol. 566, no. 1–3, pp. 25–29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. Adams and J. D. Sweatt, “Molecular psychology: roles for the ERK MAP kinase cascade in memory,” Annual Review of Pharmacology and Toxicology, vol. 42, pp. 135–163, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Patterson, E. Mengel, M. T. Vanier et al., “Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study,” Orphanet Journal of Rare Diseases, vol. 10, article 65, 2015. View at Publisher · View at Google Scholar
  26. J. B. Nietupski, J. J. Pacheco, W.-L. Chuang et al., “Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice,” Molecular Genetics and Metabolism, vol. 105, no. 4, pp. 621–628, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. R. H. Lachmann, D. Te Vruchte, E. Lloyd-Evans et al., “Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C,” Neurobiology of Disease, vol. 16, no. 3, pp. 654–658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. S. Ribas, R. Pires, J. C. Coelho et al., “Oxidative stress in Niemann-Pick type C patients: a protective role of N-butyl-deoxynojirimycin therapy,” International Journal of Developmental Neuroscience, vol. 30, no. 6, pp. 439–444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. T. D. Butters, R. A. Dwek, and F. M. Platt, “Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses,” Glycobiology, vol. 15, no. 10, pp. 43R–52R, 2005. View at Publisher · View at Google Scholar · View at Scopus